Certified by Founder Lodge
Ankyra Therapeutics
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $45,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 12 ,2021 | Series B | $45,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Whirl AI | $8,900,000 | (Apr 2, 2026)
Cara | $8,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
